U.S. Top Stock Picks from Analysts

Telephone and Data Systems

Market Cap: US$3.8b

A telecommunications company, provides communications services to consumer, business, and government in the United States.

Maximus

Market Cap: US$3.8b

Operates as a provider of government services worldwide.

Cellebrite DI

Market Cap: US$3.7b

Develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.

Workiva

Market Cap: US$3.6b

Provides cloud-based reporting solutions in the Americas and internationally.

Avidity Biosciences

Market Cap: US$3.5b

A biopharmaceutical company, engages in the delivery of RNA therapeutics called antibody oligonucleotide conjugates (AOCs).

Core Scientific

Market Cap: US$3.5b

Provides digital asset mining services in the United States.

Ultragenyx Pharmaceutical

Market Cap: US$3.5b

A biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific.

Arcellx

Market Cap: US$3.5b

Together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable diseases in the United States.

Liberty Global

Market Cap: US$3.4b

Provides broadband internet, video, fixed-line telephony, and mobile communications services to residential and business customers.

Riot Platforms

Market Cap: US$3.4b

Operates as a Bitcoin mining company in the United States.

Zeta Global Holdings

Market Cap: US$3.3b

Operates an omnichannel data-driven cloud platform that provides enterprises with consumer intelligence and marketing automation software in the United States and internationally.

GEO Group

Market Cap: US$3.2b

Owns, leases, operates, and manages secure facilities, processing centers, and community-based reentry facilities in the United States, Australia, the United Kingdom, and South Africa.

HA Sustainable Infrastructure Capital

Market Cap: US$3.1b

Through its subsidiaries, engages in the investment in energy efficiency, renewable energy, and sustainable infrastructure markets in the United States.

Metsera

Market Cap: US$3.1b

A clinical-stage biotechnology company, develops injectable and oral nutrient stimulated hormone analog peptides to treat obesity, overweight, and related diseases.

Six Flags Entertainment

Market Cap: US$3.1b

Operates amusement parks and resort properties in North America.

Globalstar

Market Cap: US$3.0b

Provides mobile satellite services in the United States, Canada, Europe, Central and South America, and internationally.

Viking Therapeutics

Market Cap: US$2.9b

A clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders.

Rumble

Market Cap: US$2.9b

Operates video sharing platforms and cloud services in the United States, Canada, and internationally.

Global Business Travel Group

Market Cap: US$2.9b

Provides business-to-business (B2B) travel platform in the United States, the United Kingdom, and internationally.

Uranium Energy

Market Cap: US$2.9b

Engages in exploration, pre-extraction, extraction, and processing of uranium and titanium concentrates properties in the United States, Canada, and the Republic of Paraguay.

Braze

Market Cap: US$2.9b

Operates a customer engagement platform that provides interactions between consumers and brands worldwide.

Alight

Market Cap: US$2.9b

A technology-enabled services company worldwide.

Alvotech

Market Cap: US$2.8b

Through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide.

Crinetics Pharmaceuticals

Market Cap: US$2.8b

A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.

MoonLake Immunotherapeutics

Market Cap: US$2.8b

A clinical stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases.

Catalyst Pharmaceuticals

Market Cap: US$2.7b

A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.

Immunovant

Market Cap: US$2.7b

A clinical-stage immunology company, develops monoclonal antibodies for the treatment of autoimmune diseases.

ImmunityBio

Market Cap: US$2.5b

A commercial stage biotechnology company, develops next-generation therapies that bolster the natural immune systems to defeat cancers and infectious diseases.

IREN

Market Cap: US$2.5b

Owns and operates bitcoin mining data centers.

CleanSpark

Market Cap: US$2.5b

Operates as a bitcoin mining company in the Americas.

Xenon Pharmaceuticals

Market Cap: US$2.5b

A neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders in Canada.

Surgery Partners

Market Cap: US$2.5b

Owns and operates a network of surgical facilities and ancillary services in the United States.

Amneal Pharmaceuticals

Market Cap: US$2.5b

A global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products worldwide.

Apogee Therapeutics

Market Cap: US$2.4b

A clinical stage biotechnology company, develops novel biologics for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other inflammatory and immunology indications.

Burford Capital

Market Cap: US$2.4b

Provides legal finance products and services worldwide.

CoreCivic

Market Cap: US$2.2b

Owns and operates partnership correctional, detention, and residential reentry facilities in the United States.